Every recall we track for Novartis Pharmaceuticals Corporation — 7 in all — plus the complaints and injury reports the public filed about them.
Novartis recalls Diovan 160mg tablets (NDC 0078-0359-34) manufactured by Patheon in Greenville, NC with lot AV5913C. Failed dissolution specifications may affect drug effectiveness.
Novartis recalls Sandimmune Oral Solution (100 mg/mL, 50mL) with crystallization risk. Affected lots from Huningue, France, expire 09/30/2024.
Novartis recalls Neoral soft gelatin capsules (25mg) due to ethanol content exceeding specifications during stability testing. This may affect medication safety for immunosuppressed patients.
Novartis recalls Xiidra (lifitegrast) eye drops due to potential impurities. Affected lots from 20E21 to 20TE2 with specific expiration dates. Consumers should check labels and contact Novartis for details.
Novartis recalls Xiidra 5% ophthalmic solution due to failed impurities and degradation specifications. Affected lots from 2019-2023; Rx only. Consumers should contact Novartis for details.
Novartis recalls Xiidra 5% professional sample solution due to failed impurities and degradation specifications. This affects specific lot numbers and requires immediate action.
Novartis recalls Xiidra 5% professional sample vials due to failed impurities and degradation specifications. This medication is for prescription use only and may pose risks if improperly stored.
